Cite Filings / AUPH
Feed Companies Filings Check
Sign in

CIK 0001600620 · Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981231763
Phone
250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
Filings Insiders Search text
All 615 Financials 84 Shareholder Meetings 7 Executive Compensation 72 Insider Trading 183 Beneficial Ownership Interest 66 Business Combinations 60 Foreign Private Issuers 205 Mutual Funds and ETFs 6 Others 74
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-21
  3. DEF 14A Proxy Proxy Statement 2025-04-17
  4. DEF 14A Proxy Proxy Statement 2024-05-03
  5. DEF 14A Proxy Proxy Statement 2023-04-18
  6. DEF 14A Proxy Proxy Statement 2022-04-18
  7. DEF 14A Proxy Proxy Statement 2021-05-10
  8. PRE 14A Proxy Proxy Statement (Preliminary) 2021-04-27

Page 1 of 1 · 7 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…